Abstract
The alpha7 nicotinic acetylcholine receptor (α7 nAChR) is widely distributed in the human brain and has been implicated in a number of human central nervous system (CNS) diseases, including Alzheimer’s and Parkinson’s disease, schizophrenia and autism. Recently, new roles for α7 nAChRs in lung cancer and heart disease have been elucidated. Despite the importance of this receptor in human pathology, many technical difficulties are still encountered when investigating the role of α7 nAChRs. Electrophysiological analysis of the receptor upon heterologous expression or in human tissues was limited by the fast desensitization of α7-mediated nicotinic currents and by tissue availability. In addition, animal models for the human diseases related to α7 nAChRs have long been unavailable. The recent development of new imaging and analysis approaches such as PET and receptor microtransplantation have rendered the study of α7 nAChRs increasingly feasible, paving new roads to the design of therapeutic drugs. This review summarizes the current knowledge and recent findings obtained by these novel approaches.
Keywords: micro-transplantation, calcium detection, pet, α7-nAChR, intracellular, positron, tomography, emisision, desensitization, heterologous
Current Drug Targets
Title:Novel Approaches to Study the Involvement of α7-nAChR in Human Diseases
Volume: 13 Issue: 5
Author(s): Eleonora Palma, Luca Conti, Cristina Roseti and Cristina Limatola
Affiliation:
Keywords: micro-transplantation, calcium detection, pet, α7-nAChR, intracellular, positron, tomography, emisision, desensitization, heterologous
Abstract: The alpha7 nicotinic acetylcholine receptor (α7 nAChR) is widely distributed in the human brain and has been implicated in a number of human central nervous system (CNS) diseases, including Alzheimer’s and Parkinson’s disease, schizophrenia and autism. Recently, new roles for α7 nAChRs in lung cancer and heart disease have been elucidated. Despite the importance of this receptor in human pathology, many technical difficulties are still encountered when investigating the role of α7 nAChRs. Electrophysiological analysis of the receptor upon heterologous expression or in human tissues was limited by the fast desensitization of α7-mediated nicotinic currents and by tissue availability. In addition, animal models for the human diseases related to α7 nAChRs have long been unavailable. The recent development of new imaging and analysis approaches such as PET and receptor microtransplantation have rendered the study of α7 nAChRs increasingly feasible, paving new roads to the design of therapeutic drugs. This review summarizes the current knowledge and recent findings obtained by these novel approaches.
Export Options
About this article
Cite this article as:
Palma Eleonora, Conti Luca, Roseti Cristina and Limatola Cristina, Novel Approaches to Study the Involvement of α7-nAChR in Human Diseases , Current Drug Targets 2012; 13 (5) . https://dx.doi.org/10.2174/138945012800398838
DOI https://dx.doi.org/10.2174/138945012800398838 |
Print ISSN 1389-4501 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-5592 |
![](/images/wayfinder.jpg)
- Author Guidelines
- Bentham Author Support Services (BASS)
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Caring for Children with Medical Complexity: Definitions, Challenges and Solutions
Current Pediatric Reviews Females Live Longer than Males: Role of Oxidative Stress
Current Pharmaceutical Design Therapeutic Potential and Pharmaceutical Applications of <i>Cucurbita</i>
Current Nutrition & Food Science Nanodiagnostic Attainments and Clinical Perspectives on C-Reactive Protein: Cardiovascular Disease Risks Assessment
Current Medicinal Chemistry Antiplatelet Therapy in Children: Why So Different from Adults’?
Current Pharmaceutical Design Biochemical Aspects of Nitric Oxide
Current Pharmaceutical Design The Heart Metabolism: Pathophysiological Aspects in Ischaemia and Heart Failure
Current Pharmaceutical Design A Combination of 3D-QSAR Modeling and Molecular Docking Approach for the Discovery of Potential HIF Prolyl Hydroxylase Inhibitors
Medicinal Chemistry Skeletal Muscle Derived Stem Cells for Myocardial Repair
Recent Patents on Cardiovascular Drug Discovery Lipoprotein(a) Management: Pharmacological and Apheretic Treatment
Current Medicinal Chemistry Pharmacology of the Human Saphenous Vein
Current Vascular Pharmacology Nutritional Antioxidants and Their Applications in Cardiometabolic Diseases
Infectious Disorders - Drug Targets Evaluation of In Vivo and In Vitro Antimicrobial Activities of a Selective Serotonin Reuptake Inhibitor Sertraline Hydrochloride
Anti-Infective Agents Immunomodulatory Activity of Garlic
Current Immunology Reviews (Discontinued) Novel Inflammatory Markers in Hyperlipidemia: Clinical Implications
Current Medicinal Chemistry Unravelling the Genetic Susceptibility to Develop Ligament and Tendon Injuries
Current Stem Cell Research & Therapy High Density Lipoprotein Cholesterol and Statin Trials
Current Medicinal Chemistry Do We Need More Research on Platelet Function in South Asian Immigrants?
Inflammation & Allergy - Drug Targets (Discontinued) Statins and Cancer
Anti-Cancer Agents in Medicinal Chemistry Transfusion-related Acute Lung Injury: An Overview
Current Pharmaceutical Design